Targeting the bone marrow microenvironment in acute leukemia

References

• Schofield R. The relationship between the spleen colony-forming cell and the haemopoietic stem cell. Blood Cells. 1978;4:7–25.
   PubMedGoogle Scholar
• Morrison SJ, Scadden DT. The bone marrow niche for haematopoietic stem cells. Nature. 2014;505:327–334.
   PubMed Web of Science ®Google Scholar
• Calvi LM, Adams GB, Weibrecht KW, et al. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature. 2003;425:841–846.
   PubMed Web of Science ®Google Scholar
• Zhang J, Niu C, Ye L, et al. Identification of the haematopoietic stem cell niche and control of the niche size. Nature. 2003;425:836–841.
   PubMed Web of Science ®Google Scholar
• Kiel MJ, Yilmaz OH, Iwashita T, et al. SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell. 2005;121:1109–1121.
   PubMed Web of Science ®Google Scholar
• Ding L, Saunders TL, Enikolopov G, et al. Endothelial and perivascular cells maintain haematopoietic stem cells. Nature. 2012;481:457–462.
   PubMed Web of Science ®Google Scholar
• Ding L, Morrison SJ. Haematopoietic stem cells and early lymphoid progenitors occupy distinct bone marrow niches. Nature. 2013;495:231–235.
   PubMed Web of Science ®Google Scholar
• Yin T, Li L. The stem cell niches in bone. J Clin Invest. 2006;116:1195–1201.
   PubMed Web of Science ®Google Scholar
• Rafii S, Shapiro F, Pettengell R, et al. Human bone marrow microvascular endothelial cells support long-term proliferation and differentiation of myeloid and megakaryocytic progenitors. Blood. 1995;86:3353–3363.
   PubMed Web of Science ®Google Scholar
• Davis TA, Robinson DH, Lee KP, et al. Porcine brain microvascular endothelial cells support the in vitro expansion of human primitive hematopoietic bone marrow progenitor cells with a high replating potential: requirement for cell-to-cell interactions and colony-stimulating factors. Blood. 1995;85:1751–1761.
   PubMed Web of Science ®Google Scholar
• Salter AB, Meadows SK, Muramoto GG, et al. Endothelial progenitor cell infusion induces hematopoietic stem cell reconstitution in vivo. Blood. 2009;113:2104–2107.
   PubMed Web of Science ®Google Scholar
• Brandt JE, Bartholomew AM, Fortman JD, et al. Ex vivo expansion of autologous bone marrow CD34(+) cells with porcine microvascular endothelial cells results in a graft capable of rescuing lethally irradiated baboons. Blood. 1999;94:106–113.
   PubMed Web of Science ®Google Scholar
• Taichman RS, Reilly MJ, Emerson SG. Human osteoblasts support human hematopoietic progenitor cells in vitro bone marrow cultures. Blood. 1996;87:518–524.
   PubMed Web of Science ®Google Scholar
• Visnjic D, Kalajzic Z, Rowe DW, et al. Hematopoiesis is severely altered in mice with an induced osteoblast deficiency. Blood. 2004;103:3258–3264.
   PubMed Web of Science ®Google Scholar
• Arai F, Hirao A, Ohmura M, et al. Tie2/Angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche. Cell. 2004;118:149–161.
   PubMed Web of Science ®Google Scholar
• Sugiyama T, Kohara H, Noda M, et al. Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches. Immunity. 2006;25:977–988.
   PubMed Web of Science ®Google Scholar
• Mendez-Ferrer S, Michurina TV, Ferraro F, et al. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature. 2010;466:829–834.
   PubMed Web of Science ®Google Scholar
• Kunisaki Y, Bruns I, Scheiermann C, et al. Arteriolar niches maintain haematopoietic stem cell quiescence. Nature. 2013;502:637–643.
   PubMed Web of Science ®Google Scholar
• Itkin T, Gur-Cohen S, Spencer JA, et al. Distinct bone marrow blood vessels differentially regulate haematopoiesis. Nature. 2016;532:323–328.
   PubMed Web of Science ®Google Scholar
• Winkler IG, Sims NA, Pettit AR, et al. Bone marrow macrophages maintain hematopoietic stem cell (HSC) niches and their depletion mobilizes HSCs. Blood. 2010;116:4815–4828.
   PubMed Web of Science ®Google Scholar
• Chow A, Lucas D, Hidalgo A, et al. Bone marrow CD169+ macrophages promote the retention of hematopoietic stem and progenitor cells in the mesenchymal stem cell niche. J Exp Med. 2011;208:261–271.
   PubMed Web of Science ®Google Scholar
• Gordon MY, Riley GP, Clarke D. Heparan sulfate is necessary for adhesive interactions between human early hemopoietic progenitor cells and the extracellular matrix of the marrow microenvironment. Leukemia. 1988;2:804–809.
   PubMed Web of Science ®Google Scholar
• Saez B, Ferraro F, Yusuf RZ, et al. Inhibiting stromal cell heparan sulfate synthesis improves stem cell mobilization and enables engraftment without cytotoxic conditioning. Blood. 2014;124:2937–2947.
   PubMed Web of Science ®Google Scholar
• Stier S, Ko Y, Forkert R, et al. Osteopontin is a hematopoietic stem cell niche component that negatively regulates stem cell pool size. J Exp Med. 2005;201:1781–1791.
   PubMed Web of Science ®Google Scholar
• Parmar K, Mauch P, Vergilio JA, et al. Distribution of hematopoietic stem cells in the bone marrow according to regional hypoxia. Proc Natl Acad Sci USA. 2007;104:5431–5436.
   PubMed Web of Science ®Google Scholar
• Spencer JA, Ferraro F, Roussakis E, et al. Direct measurement of local oxygen concentration in the bone marrow of live animals. Nature. 2014;508:269–273.
   PubMed Web of Science ®Google Scholar
• Walkley CR, Olsen GH, Dworkin S, et al. A microenvironment-induced myeloproliferative syndrome caused by retinoic acid receptor gamma deficiency. Cell. 2007;129:1097–1110.
   PubMed Web of Science ®Google Scholar
• Kim YW, Koo BK, Jeong HW, et al. Defective Notch activation in microenvironment leads to myeloproliferative disease. Blood. 2008;112:4628–4638.
   PubMed Web of Science ®Google Scholar
• Fulzele K, Krause DS, Panaroni C, et al. Myelopoiesis is regulated by osteocytes through Gsα-dependent signaling. Blood. 2013;121:930–939.
   PubMed Web of Science ®Google Scholar
• Raaijmakers MH, Mukherjee S, Guo S, et al. Bone progenitor dysfunction induces myelodysplasia and secondary leukaemia. Nature. 2010;464:852–857.
   PubMed Web of Science ®Google Scholar
• Kode A, Manavalan JS, Mosialou I, et al. Leukaemogenesis induced by an activating β-catenin mutation in osteoblasts. Nature. 2014;506:240–244.
   PubMed Web of Science ®Google Scholar
• Sala-Torra O, Hanna C, Loken MR, et al. Evidence of donor-derived hematologic malignancies after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2006;12:511–517.
   PubMed Web of Science ®Google Scholar
• Krause DS, Scadden DT. A hostel for the hostile: the bone marrow niche in hematologic neoplasms. Haematologica. 2015;100:1376–1387.
   PubMed Web of Science ®Google Scholar
• Kortlepel K, Bendall LJ, Gottlieb DJ. Human acute myeloid leukaemia cells express adhesion proteins and bind to bone marrow fibroblast monolayers and extracellular matrix proteins. Leukemia. 1993;7:1174–1179.
   PubMed Web of Science ®Google Scholar
• Reuss-Borst MA, Buhring HJ, Klein G, et al. Adhesion molecules on CD34+ hematopoietic cells in normal human bone marrow and leukemia. Ann Hematol. 1992;65:169–174.
   PubMed Web of Science ®Google Scholar
• Liesveld JL, Winslow JM, Kempski MC, et al. Adhesive interactions of normal and leukemic human CD34+ myeloid progenitors: role of marrow stromal, fibroblast, and cytomatrix components. Exp Hematol. 1991;19:63–70.
   PubMed Web of Science ®Google Scholar
• Lesley J, Hyman R, Kincade PW. CD44 and its interaction with extracellular matrix. Adv Immunol. 1993;54:271–335.
   PubMed Web of Science ®Google Scholar
• Dimitroff CJ, Lee JY, Rafii S, et al. CD44 is a major E-selectin ligand on human hematopoietic progenitor cells. J Cell Biol. 2001;153:1277–1286.
   PubMed Web of Science ®Google Scholar
• Bendall LJ, Bradstock KF, Gottlieb DJ. Expression of CD44 variant exons in acute myeloid leukemia is more common and more complex than that observed in normal blood, bone marrow or CD34+ cells. Leukemia. 2000;14:1239–1246.
   PubMed Web of Science ®Google Scholar
• Legras S, Gunthert U, Stauder R, et al. A strong expression of CD44-6v correlates with shorter survival of patients with acute myeloid leukemia. Blood. 1998;91:3401–3413.
   PubMed Web of Science ®Google Scholar
• Jin L, Hope KJ, Zhai Q, et al. Targeting of CD44 eradicates human acute myeloid leukemic stem cells. Nat Med. 2006;12:1167–1174.
   PubMed Web of Science ®Google Scholar
• Quere R, Andradottir S, Brun AC, et al. High levels of the adhesion molecule CD44 on leukemic cells generate acute myeloid leukemia relapse after withdrawal of the initial transforming event. Leukemia. 2011;25:515–526.
   PubMed Web of Science ®Google Scholar
• Krause DS, Spitzer TR, Stowell CP. The concentration of CD44 is increased in hematopoietic stem cell grafts of patients with acute myeloid leukemia, plasma cell myeloma, and non-Hodgkin lymphoma. Arch Pathol Lab Med. 2010;134:1033–1038.
   PubMed Web of Science ®Google Scholar
• Erb U, Megaptche AP, Gu X, et al. CD44 standard and CD44v10 isoform expression on leukemia cells distinctly influences niche embedding of hematopoietic stem cells. J Hematol Oncol. 2014;7:29.
   PubMed Web of Science ®Google Scholar
• Singh V, Erb U, Zoller M. Cooperativity of CD44 and CD49d in leukemia cell homing, migration, and survival offers a means for therapeutic attack. J Immunol. 2013;191:5304–5316.
   PubMed Web of Science ®Google Scholar
• Joshi I, Jena N, Yoshida T, et al. Focal adhesion kinase inhibitors reverse the stromal adhesion phenotype of ikaros-mutant B-ALL, induce apopotosis, and synergize with ABL1 tyrosine kinase inhibitors: a new paradigm for pathogenesis and therapy of high-risk B-ALL. Blood. 2014;124:285–285.
   Web of Science ®Google Scholar
• Churchman ML, Evans K, Richmond J, et al. Synergism of FAK and tyrosine kinase inhibition in Ph + B-ALL. JCI Insight. 2016;1(4):e86082.
   PubMed Web of Science ®Google Scholar
• Miller PG, Al-Shahrour F, Hartwell KA, et al. In vivo RNAi screening identifies a leukemia-specific dependence on integrin beta 3 signaling. Cancer Cell. 2013;24:45–58.
   PubMed Web of Science ®Google Scholar
• Bajaj J, Konuma T, Lytle NK, et al. CD98-mediated adhesive signaling enables the establishment and propagation of acute myelogenous leukemia. Cancer Cell. 2016;30:792–805.
   PubMed Web of Science ®Google Scholar
• Kumar B, Garcia M, Weng L, et al. Acute myeloid leukemia transforms the bone marrow niche into a leukemia-permissive microenvironment through exosome secretion. Leukemia. 2017 [Aug 17]. doi: 10.1038/leu.2017.259
   Web of Science ®Google Scholar
• Fei F, Joo EJ, Tarighat SS, et al. B-cell precursor acute lymphoblastic leukemia and stromal cells communicate through Galectin-3. Oncotarget. 2015;6:11378–11394.
   PubMed Web of Science ®Google Scholar
• Naderi EH, Skah S, Ugland H, et al. Bone marrow stroma-derived PGE2 protects BCP-ALL cells from DNA damage-induced p53 accumulation and cell death. Mol Cancer. 2015;14:14.
   PubMed Web of Science ®Google Scholar
• Pitt LA, Tikhonova AN, Hu H, et al. CXCL12-producing vascular endothelial niches control acute T cell leukemia maintenance. Cancer Cell. 2015;27:755–768.
   PubMed Web of Science ®Google Scholar
• Polak R, de Rooij B, Pieters R, et al. B-cell precursor acute lymphoblastic leukemia cells use tunneling nanotubes to orchestrate their microenvironment. Blood. 2015;126:2404–2414.
   PubMed Web of Science ®Google Scholar
• Frisch BJ, Ashton JM, Xing L, et al. Functional inhibition of osteoblastic cells in an in vivo mouse model of myeloid leukemia. Blood. 2012;119:540–550.
   PubMed Web of Science ®Google Scholar
• Wang Y, Gao A, Zhao H, et al. Leukemia cell infiltration causes defective erythropoiesis partially through MIP-1alpha/CCL3. Leukemia. 2016;30:1897–1908.
   PubMed Web of Science ®Google Scholar
• Battula VL, Le PM, Sun JC, et al. AML-induced osteogenic differentiation in mesenchymal stromal cells supports leukemia growth. JCI Insight. 2017 [Jul 6]. doi: 10.1172/jci.insight.90036
   PubMed Web of Science ®Google Scholar
• Hawkins ED, Duarte D, Akinduro O, et al. T-cell acute leukaemia exhibits dynamic interactions with bone marrow microenvironments. Nature. 2016;538:518–522.
   PubMed Web of Science ®Google Scholar
• Hu K, Gu Y, Lou L, et al. Galectin-3 mediates bone marrow microenvironment-induced drug resistance in acute leukemia cells via Wnt/beta-catenin signaling pathway. J Hematol Oncol. 2015;8:1. doi: 10.1186/s13045-014-0099-8
   PubMed Web of Science ®Google Scholar
• Hanoun M, Zhang D, Mizoguchi T, et al. Acute myelogenous leukemia-induced sympathetic neuropathy promotes malignancy in an altered hematopoietic stem cell niche. Cell Stem Cell. 2014;15:365–375.
   PubMed Web of Science ®Google Scholar
• Passaro D, Di Tullio A, Abarrategi A, et al. Increased vascular permeability in the bone marrow microenvironment contributes to disease progression and drug response in acute myeloid leukemia. Cancer Cell. 2017;32:324–341 e326.
   PubMed Web of Science ®Google Scholar
• Yusuf RZ, Wang YH, Scadden DT. The secrets of the bone marrow niche: metabolic priming for AML. Nat Med. 2012;18:865–867.
   PubMedGoogle Scholar
• Lokody I. Metabolism: IDH2 drives cancer in vivo. Nat Rev Cancer. 2013;13:756–757.
   PubMed Web of Science ®Google Scholar
• He M, Wang QY, Yin QQ, et al. HIF-1alpha downregulates miR-17/20a directly targeting p21 and STAT3: a role in myeloid leukemic cell differentiation. Cell Death Differ. 2013;20:408–418.
   PubMed Web of Science ®Google Scholar
• Forristal CE, Brown AL, Helwani FM, et al. Hypoxia inducible factor (HIF)-2α accelerates disease progression in mouse models of leukemia and lymphoma but is not a poor prognosis factor in human AML. Leukemia. 2015;29:2075–2085.
   PubMed Web of Science ®Google Scholar
• Liersch R, Gerss J, Schliemann C, et al. Osteopontin is a prognostic factor for survival of acute myeloid leukemia patients. Blood. 2012;119:5215–5220.
   PubMed Web of Science ®Google Scholar
• Boyerinas B, Zafrir M, Yesilkanal AE, et al. Adhesion to osteopontin in the bone marrow niche regulates lymphoblastic leukemia cell dormancy. Blood. 2013;121:4821–4831.
   PubMed Web of Science ®Google Scholar
• Hsieh YT, Gang EJ, Geng H, et al. Integrin alpha4 blockade sensitizes drug resistant pre-B acute lymphoblastic leukemia to chemotherapy. Blood. 2013;121:1814–1818.
   PubMed Web of Science ®Google Scholar
• Zeng Z, Liu W, Tsao T, etet al. High-throughput profiling of signaling networks identifies mechanism-based combination therapy to eliminate microenvironmental resistance in acute myeloid leukemia. Haematologica. 2017;102(9):1537–1548.
   PubMed Web of Science ®Google Scholar
• Moschoi R, Imbert V, Nebout M, et al. Protective mitochondrial transfer from bone marrow stromal cells to acute myeloid leukemic cells during chemotherapy. Blood. 2016;128:253–264.
   PubMed Web of Science ®Google Scholar
• Ishikawa F, Yoshida S, Saito Y, et al. Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region. Nat Biotechnol. 2007;25:1315–1321.
   PubMed Web of Science ®Google Scholar
• Bosse RC, Wasserstrom B, Meacham A, et al. Chemosensitizing AML cells by targeting bone marrow endothelial cells. Exp Hematol. 2016;44:363–377 e365.
   PubMed Web of Science ®Google Scholar
• Winkler IG, Barbier V, Nowlan B, et al. Vascular niche E-selectin regulates hematopoietic stem cell dormancy, self renewal and chemoresistance. Nat Med. 2012;18:1651–1657.
   PubMed Web of Science ®Google Scholar
• Sipkins DA, Wei X, Wu JW, et al. In vivo imaging of specialized bone marrow endothelial microdomains for tumour engraftment. Nature. 2005;435:969–973.
   PubMed Web of Science ®Google Scholar
• Winkler IG, Barbier V, Pattabiraman DR, Gonda TJ, Magnani JL, Levesque J-P. Vascular niche E-selectin protects acute myeloid leukaemia stem cells from chemotherapy. Blood. 2014;124:620.
   Web of Science ®Google Scholar
• Juarez J, Bradstock KF, Gottlieb DJ, et al. Effects of inhibitors of the chemokine receptor CXCR4 on acute lymphoblastic leukemia cells in vitro. Leukemia. 2003;17:1294–1300.
   PubMed Web of Science ®Google Scholar
• Sison EA, Magoon D, Li L, et al. Plerixafor as a chemosensitizing agent in pediatric acute lymphoblastic leukemia: efficacy and potential mechanisms of resistance to CXCR4 inhibition. Oncotarget. 2014;5:8947–8958.
   PubMed Web of Science ®Google Scholar
• Abraham M, Klein S, Bulvik B, etet al. The CXCR4 inhibitor BL-8040 induces the apoptosis of AML blasts by downregulating ERK, BCL-2, MCL-1 and cyclin-D1 via altered miR-15a/16-1 expression. Leukemia. 2017; 31:2336–2346.
   PubMed Web of Science ®Google Scholar
• Becker PS, Kopecky KJ, Wilks AN, et al. Very late antigen-4 function of myeloblasts correlates with improved overall survival for patients with acute myeloid leukemia. Blood. 2009;113:866–874.
   PubMed Web of Science ®Google Scholar
• Zaitseva L, Murray MY, Shafat MS, et al. Ibrutinib inhibits SDF1/CXCR4 mediated migration in AML. Oncotarget. 2014;5:9930–9938.
   PubMed Web of Science ®Google Scholar
• Ben-Batalla I, Schultze A, Wroblewski M, et al. Axl, a prognostic and therapeutic target in acute myeloid leukemia mediates paracrine crosstalk of leukemia cells with bone marrow stroma. Blood. 2013;122:2443–2452.
   PubMed Web of Science ®Google Scholar
• Benito J, Ramirez MS, Millward NZ, et al. Hypoxia-activated prodrug TH-302 Targets Hypoxic Bone Marrow Niches in Preclinical Leukemia Models. Clin Cancer Res. 2016;22:1687–1698.
   PubMed Web of Science ®Google Scholar
• Pillinger G, Loughran NV, Piddock RE, et al. Targeting PI3Kdelta and PI3Kgamma signalling disrupts human AML survival and bone marrow stromal cell mediated protection. Oncotarget. 2016;7:39784–39795.
   PubMedGoogle Scholar
• Hartwell KA, Miller PG, Mukherjee S, et al. Niche-based screening identifies small-molecule inhibitors of leukemia stem cells. Nat Chem Biol. 2013;9:840–848.
   PubMed Web of Science ®Google Scholar
• Nair MS, Mony U, Menon D, et al. Development and molecular characterization of polymeric micro-nanofibrous scaffold of a defined 3-D niche for in vitro chemosensitivity analysis against acute myeloid leukemia cells. Int J Nanomed. 2015;10:3603–3622.
   PubMed Web of Science ®Google Scholar
• Houshmand M, Soleimani M, Atashi A, et al. Mimicking the acute myeloid leukemia niche for molecular study and drug screening. Tissue Eng Part C Methods. 2017;23:72–85.
   PubMed Web of Science ®Google Scholar